Provided by Tiger Trade Technology Pte. Ltd.

ABVC BioPharma, Inc.

1.13
-0.1000-8.13%
Volume:40.67K
Turnover:47.78K
Market Cap:28.73M
PE:-2.87
High:1.23
Open:1.23
Low:1.13
Close:1.23
52wk High:5.48
52wk Low:0.6880
Shares:25.42M
Float Shares:20.60M
Volume Ratio:0.75
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3933
EPS(LYR):-0.3933
ROE:-119.49%
ROA:-31.25%
PB:2.59
PE(LYR):-2.87

Loading ...

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Nov 01, 2025

ABVC Biopharma Ties Executive Compensation to $1B Market Cap Milestone

Reuters
·
Oct 30, 2025

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

GlobeNewswire
·
Oct 30, 2025

Supernus Pharmaceuticals Advances ADHD Treatment Study in Young Children

TIPRANKS
·
Oct 28, 2025

AbbVie’s Fosigotifator Study Termination: Impact on MDD Treatment Pipeline

TIPRANKS
·
Oct 28, 2025

Cingulate’s Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting

GlobeNewswire
·
Oct 24, 2025

Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences

GlobeNewswire
·
Oct 22, 2025

FDA Accepts Cingulate’s New Drug Application for CTx-1301 in Attention-Deficit/Hyperactivity Disorder (ADHD) and sets a May 31, 2026 PDUFA Date

GlobeNewswire
·
Oct 14, 2025

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing

GlobeNewswire
·
Oct 13, 2025

Thomas Brown, Who Busted Myths Related to ADHD, Dies at 83 -- Journal Report

Dow Jones
·
Oct 10, 2025

Does Tylenol Cause Autism? Here's How We Could Find Out -- WSJ

Dow Jones
·
Oct 03, 2025

Jardine Matheson Group charity MINDSET launches Unlocking ADHD–MINDSET Support Hub, pledges $1 million

The Edge Singapore
·
Oct 02, 2025

Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device

GlobeNewswire
·
Sep 30, 2025